Literature DB >> 12109660

Gastric mucosa: long-term outcome after cure of Helicobacter pylori infection.

Francesco Franceschi1, Robert M Genta, Antonio R Sepulveda.   

Abstract

The histopathological changes due to chronic Helicobacter pylori infection are well characterized. Nevertheless, the clinical and pathological outcomes resulting from the cure of this infection remain incompletely described. In particular, the influence of eradication of H. pylori on nonulcer dyspepsia, the long-term effects of H. pylori eradication on gastric atrophy and intestinal metaplasia, and the role of H. pylori eradication in the prevention of gastric cancer are still unclear. We reviewed 38 studies reported between 1993 and 1999 on the outcome of various disorders related to H. pylori infection after successful eradication. There is general agreement concerning the regression of chronic gastritis, lymphoid follicles, and limited-stage low-grade MALT lymphomas of the gastric mucosa after eradication of H. pylori infection. Conversely, there are still major questions on whether H. pylori eradication improves the outcome of premalignant lesions, such as atrophy, intestinal metaplasia, and dysplasia. Finally, some extragastric idiopathic diseases seem to improve in consequence of the eradication of the infection, although there are still no definitive data to support this.

Entities:  

Mesh:

Year:  2002        PMID: 12109660     DOI: 10.1007/bf02990094

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  55 in total

1.  Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study.

Authors:  R W Van der Hulst; E A Rauws; B Köycü; J J Keller; M J Bruno; J G Tijssen; G N Tytgat
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

2.  Pathological consequences of Helicobacter pylori infection.

Authors:  M Dixon
Journal:  Scand J Gastroenterol Suppl       Date:  1996

3.  Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa.

Authors:  Y Yamaoka; M Kita; T Kodama; N Sawai; J Imanishi
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

4.  Long-term follow-up of disappearance of gastric mucosa-associated lymphoid tissue after anti-Helicobacter pylori therapy.

Authors:  A Tursi; G Cammarota; A Papa; L Cuoco; G Fedeli; G Gasbarrini
Journal:  Am J Gastroenterol       Date:  1997-10       Impact factor: 10.864

5.  Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis.

Authors:  G D Eslick; L L Lim; J E Byles; H H Xia; N J Talley
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

6.  Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon.

Authors:  A Gasbarrini; I Massari; M Serricchio; P Tondi; A De Luca; F Franceschi; V Ojetti; A Dal Lago; R Flore; A Santoliquido; G Gasbarrini; P Pola
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

7.  Prevalence of Helicobacter pylori-associated gastritis in chronic urticaria.

Authors:  B Wedi; S Wagner; T Werfel; M P Manns; A Kapp
Journal:  Int Arch Allergy Immunol       Date:  1998-08       Impact factor: 2.749

Review 8.  Mucosa-associated lymphoid tissue lymphoma.

Authors:  P G Isaacson
Journal:  Semin Hematol       Date:  1999-04       Impact factor: 3.851

9.  Helicobacter pylori exotoxins and gastroduodenal diseases associated with cytotoxic strain infection.

Authors:  N Figura
Journal:  Aliment Pharmacol Ther       Date:  1996-04       Impact factor: 8.171

10.  Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.

Authors:  E Bayerdörffer; A Neubauer; B Rudolph; C Thiede; N Lehn; S Eidt; M Stolte
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

View more
  3 in total

1.  Basis of decreased risk of gastric cancer in severe atrophic gastritis with eradication of Helicobacter pylori.

Authors:  Akira Tari; Yasuhiko Kitadai; Masaharu Sumii; Atsunori Sasaki; Hiroshi Tani; Sinji Tanaka; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2006-12-07       Impact factor: 3.487

Review 2.  Kyoto global consensus report on Helicobacter pylori gastritis.

Authors:  Kentaro Sugano; Jan Tack; Ernst J Kuipers; David Y Graham; Emad M El-Omar; Soichiro Miura; Ken Haruma; Masahiro Asaka; Naomi Uemura; Peter Malfertheiner
Journal:  Gut       Date:  2015-07-17       Impact factor: 23.059

3.  Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors.

Authors:  Hebin Che; Qi Xiong; Jinxia Ma; Shixue Chen; Huan Wu; Hongli Xu; Baicun Hou
Journal:  BMC Cancer       Date:  2022-08-19       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.